MedPath

Posterior Capsule Opacification (PCO) With AcrySof Single-Piece IOL

Not Applicable
Completed
Conditions
Posterior Capsule Opacification
Interventions
Procedure: Phaco
Registration Number
NCT00855491
Lead Sponsor
Iladevi Cataract and IOL Research Center
Brief Summary

The purpose of this study what to evaluate if axial myopia might influence the development of PCO.

Detailed Description

We sought to prospectively compare PCO in eyes with myopia in relation to axial length with PCO in eyes with normal axial length, to decipher the role of axial myopia in PCO 4 years after surgery for senile cataract.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • local residency and presence of a cataract in an otherwise normal eye.
  • Patients older than 50 years
  • a dilated pupil after mydriasis
  • Patients with retinochoroidal atrophy, retinal laser prophylaxis,
  • hypertension
Exclusion Criteria
  • nondilating pupil after maximal dilation;
  • pseudoexfoliation; mature, traumatic, black, or complicated cataracts;
  • previous intraocular surgery;
  • previous surgery for glaucoma;
  • uveitis
  • diabetes mellitus
  • Patients who did not give consent preoperatively

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1. MYOPIAPhacoaxial length \> 26.00 mm
2. EmmetropiaPhacoemmetropic eyes- eyes with an axial length of 21.00 to 23.99 mm
Primary Outcome Measures
NameTimeMethod
the percentage area of PCO with posterior capsule opacity (POCO) software4 years
Secondary Outcome Measures
NameTimeMethod
the presence of PCO within the central 3-mm zone were noted4 years

Trial Locations

Locations (1)

Raghudeep Eye Clinic

🇮🇳

Ahmedabad, gUJARAT, India

© Copyright 2025. All Rights Reserved by MedPath